Inventor

Wang xiaozhao

US46 patents

⚠️ This page may combine multiple inventors who share the name “Wang xiaozhao”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

Wang xiaozhao

INCYTE CORP

Bicyclic heterocycles as FGFR4 inhibitors

Cyclopropylamines as LSD1 inhibitors

Pyrrolotriazine compounds as tam inhibitors

Triazolopyridines and triazolopyrazines as LSD1 inhibitors

Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors

Substituted triazolo[1,5-a]pyridines and triazolo[1,5-a]pyrazines as LSD1 inhibitors

Cyclopropylamines as LSD1 inhibitors

Pyrrolopyrimidine derivatives as TAM inhibitors

Pyrrolotriazine compounds as TAM inhibitors

Cyclopropylamines as LSD1 inhibitors

Fused pyrazine derivatives as A2A / A2B inhibitors

Pyrrolopyrimidine derivatives as TAM inhibitors

Substituted [1,2,4]triazolo[1,5-a]pyrazines as LSD1 inhibitors

Pyrrolotriazine compounds as TAM inhibitors

Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors

Pyrrolotriazine compounds as TAM inhibitors

Triazolopyridines and triazolopyrazines as LSD1 inhibitors

Substituted [1,2,4]triazolo[1,5-a]pyridines and substituted [1,2,4]triazolo[1,5-a]pyrazines as LSD1 inhibitors

Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors

Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors

Pyrazolopyridines and triazolopyridines as A2A / A2B inhibitors

Cyclopropylamines as LSD1 inhibitors

Pyrrolopyrimidine derivatives as TAM inhibitors

Spiro compounds as inhibitors of KRAS

Fused pyrimidine derivatives as A2A / A2B inhibitors

Pyrazoloquinoline KRAS inhibitors

Pyrrolotriazine compounds as tam inhibitors

Bicyclic amines as CDK2 inhibitors

Pyrazolopyridines and triazolopyridines as A2A / A2B inhibitors

Quinoline compounds as inhibitors of KRAS

Fused pyrimidine derivatives as A2A/A2B inhibitors

Fused pyrazine derivatives as A2A / A2B inhibitors

Quinoline compounds as inhibitors of KRAS

Imidazole and triazole KRAS inhibitors

Bicyclic dione compounds as inhibitors of KRAS

CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination therapy

Hetero-tricyclic compounds as inhibitors of KRAS

Pyrrole tricyclic compounds as A2A / A2B inhibitors

Tricyclic compounds as inhibitors of KRAS

Fused pyrimidine compounds as KRAS inhibitors

Naphthyridine compounds as inhibitors of KRAS

Hetero-bicyclic inhibitors of KRAS

Vinyl imidazole compounds as inhibitors of KRAS

Heterocyclic compounds and uses thereof

UNIV PENNSYLVANIA

Cycloalkyl-dione derivatives and methods of their use

Thromboxane A2 (TP) receptor antagonists